Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Filings indexed 963 across all filing types
Latest filing 2021-01-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
2021年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the convening, procedures, attendance, and voting results of a company's 2021 first extraordinary general meeting (临时股东大会). It discusses the qualifications of the convener, attendees, voting procedures, and the resolution passed at the meeting. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholder meeting and its resolutions. This type of document does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a simple announcement or notice but a formal legal opinion. The closest fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories. The document length is under 5,000 characters, but it is not merely an announcement of a report publication; it is a substantive legal opinion document. Therefore, the best classification is Regulatory Filings (RNS).
2021-01-15 Chinese
关于2020年度获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about government subsidies received during the fiscal year 2020. It details the amounts, types, and accounting treatment of these subsidies, including their impact on the company's profit. The document is relatively short (4201 characters) and does not contain comprehensive financial statements or detailed financial analysis. It is not a full annual or interim report, nor is it a management discussion or earnings release. It is a regulatory announcement informing shareholders and the market about government grants and their accounting treatment. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-01-03 Chinese
关于召开2021年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2021 first extraordinary general meeting (临时股东大会) of the company, including information on meeting date, voting methods (onsite and online), agenda items, registration procedures, and attachments such as proxy forms and voting instructions. It does not contain financial statements or results but is a formal announcement to shareholders about the meeting and how to participate and vote. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document is about a shareholders meeting and voting, not the results of voting or the meeting itself, so it is not a Declaration of Voting Results (DVA). It is not an Annual Report, Interim Report, or any financial report. Therefore, the correct classification is PSI with high confidence.
2020-12-29 Chinese
第二届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 12th meeting of the second board of directors of the company. It includes details about board decisions such as stock repurchase proposals, scheduling a shareholders meeting, and approval of foreign exchange hedging business. The document contains voting results and references to further announcements on other platforms. It is not a full report like an annual or interim report, nor is it a transcript or financial supplement. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and it is an announcement of decisions rather than a detailed report, confirming it is not a full report but a management information announcement.
2020-12-29 Chinese
关于回购注销部分限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the company's repurchase and cancellation of part of its restricted stock under a 2018 restricted stock incentive plan. It includes information about board and supervisory meetings, approvals, pricing, reasons for repurchase, and legal opinions. The content focuses on a specific capital change event related to share repurchase and cancellation of restricted shares. There are no financial statements or earnings data, nor is this a general regulatory filing or a report publication announcement. The document fits the category of a share repurchase or capital change announcement, specifically about repurchasing and canceling shares. Therefore, the appropriate classification is 'Transaction in Own Shares (POS)'. The document length (5344 characters) and detailed content support a high confidence in this classification.
2020-12-29 Chinese
上海市锦天城律师事务所关于公司回购注销2018年限制性股票激励计划部分激励股份的法律意见书
Transaction in Own Shares Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the repurchase and cancellation of restricted shares under a 2018 stock incentive plan by a company. It details the legal basis, approvals, authorizations, reasons, quantities, prices, and funding sources for the repurchase and cancellation of restricted stock. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to a specific corporate action involving share repurchase and cancellation. This fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares, including share repurchase and cancellation activities. The document length is sufficient and contains substantive content, not merely an announcement or certification, so it is not RPA or RNS. Therefore, the appropriate classification is POS with high confidence.
2020-12-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.